
Sign up to save your podcasts
Or


Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.
By Glaucoma Today5
1010 ratings
Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.

91,097 Listeners

43 Listeners

18 Listeners

97 Listeners

112,574 Listeners

8,995 Listeners

159 Listeners

8 Listeners

11 Listeners

10 Listeners

52 Listeners

10 Listeners

16 Listeners

18 Listeners

0 Listeners